scispace - formally typeset
D

David W. Griggs

Researcher at Saint Louis University

Publications -  64
Citations -  3530

David W. Griggs is an academic researcher from Saint Louis University. The author has contributed to research in topics: Integrin & Fibrosis. The author has an hindex of 21, co-authored 60 publications receiving 3017 citations. Previous affiliations of David W. Griggs include Pfizer & Washington University in St. Louis.

Papers
More filters
Journal ArticleDOI

Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5.

TL;DR: Despite the apparent dominant role of ADAMTS-5 in genetically modified mice, the data suggest that both ADAMts-4 and ADAM TS-5 contribute to the structural damage that characterizes human OA.
Journal ArticleDOI

A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo.

TL;DR: A synthetic chemical peptide mimetic based upon the alpha(v)beta3 ligand, Arg-Gly-Asp (RGD), which recognizes the isolated integrin, and its relative, alpha( v)beta5, as effectively as does the natural peptide, dampens osteoclastic bone resorption in vitro and in vivo.
Journal ArticleDOI

Inhibition of αvβ3 Integrin Survival Signaling Enhances Antiangiogenic and Antitumor Effects of Radiotherapy

TL;DR: It is shown that combined treatment with S247, an Arg-Gly-Glu peptidomimetic antagonist of αvβ3 integrin, and external beam radiotherapy are beneficial in local tumor therapy and that the combination of integrin antagonists and radiotherapy represents a rational approach in local cancer therapy.
Journal ArticleDOI

Regulated expression of the GAL4 activator gene in yeast provides a sensitive genetic switch for glucose repression

TL;DR: The results suggest that GAL4 works synergistically to activate GAL1 expression, illustrating how modest regulation of a weakly expressed regulatory gene can act as a sensitive genetic switch to produce greatly amplified responses to environmental changes.